Innate Pharma (IPHA) Long-Term Deferred Tax (2018 - 2024)
Innate Pharma's Long-Term Deferred Tax was $9.82 million in the quarter ended Jun 30, 2024, down 6.7% from $10.53 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Long-Term Deferred Tax (2018 - 2024) Analysis & Trends
As of Dec 31, 2023, Long-Term Deferred Tax at Innate Pharma came in at $9.74 million, up 7.9% from the prior year.
- Long-Term Deferred Tax shows a five-year compound annual growth rate of 40.5% (years ended Dec 2018 to Dec 2023).
- In earlier years, Long-Term Deferred Tax was $9.03 million in the year ended Dec 31, 2022 (+57.0%), $5.75 million in the year ended Dec 31, 2021 (-28.9%), $8.09 million in the year ended Dec 31, 2020 (+529.2%) and $1.29 million in the year ended Dec 31, 2019 (-27.8%).
- Quarterly Long-Term Deferred Tax has moved between $1.27 million (the quarter ended Jun 30, 2020) and $10.53 million (the quarter ended Jun 30, 2023) over five years.
- Compared with a year earlier, Long-Term Deferred Tax was higher in three of the last four quarters, with growth averaging 20.8%.
- The best year-over-year quarter for Long-Term Deferred Tax over five years was the quarter ended Dec 31, 2020 (growth of 493.6%); the worst was the quarter ended Dec 31, 2021 (a decline of 31.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Innate Pharma | 149.95 Mn | 149.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 9.82 Mn |
| Dec 31, 2023 | 9.69 Mn |
| Jun 30, 2023 | 10.53 Mn |
| Dec 31, 2022 | 8.74 Mn |
| Jun 30, 2022 | 8.30 Mn |
| Dec 31, 2021 | 5.75 Mn |
| Jun 30, 2021 | 6.50 Mn |
| Dec 31, 2020 | 8.45 Mn |
| Jun 30, 2020 | 1.27 Mn |
| Dec 31, 2019 | 1.42 Mn |
| Dec 31, 2018 | 1.78 Mn |
API Access
Innate Pharma Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();